#231 | Should You Export Your MedTech Product to One European Market or Several?

When exporting your MedTech product to Europe, should you focus everything on one market first or test several countries at the same time?That's exactly the unresolved question. We're not telling them the answer.Choosing where to start in Europe isn't simply about finding the country with the biggest MedTech market. Different countries can have very different reimbursement pathways, adoption barriers, competition, KOL support and routes to market. In this Decision Point episode, Hakeem revisits his conversation with Laurent Laffineur to explore whether your European export strategy should focus on one market, test several carefully selected countries, or start somewhere smaller where you can prove your commercial model before scaling. In this episode you'll discover:Why the biggest European MedTech market isn't automatically the best place to invest your export budget first.The advantages of testing your go-to-market strategy across two or three carefully selected European markets rather than assuming success in one country can simply be duplicated elsewhere. How customer access, adoption barriers, competition, KOL relationships and the cost of proving commercial traction can help you decide where to concentrate your investment. Listen now to discover how to approach your first European export markets and decide where to invest your MedTech go-to-market budget before committing significant resources to expansion.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.